In accordance with ACR recommendations, allopurinol is strongly suggested as a first-line urate-reducing medication. Genetic screening is recommended (to get a variant named HLA B*5801) just before starting off allopurinol because the carriers of this gene are at an elevated possibility of a extreme allergic response.As being a company to our audie